- Home
- Industry Reports
- Biotechnology
- Healthcare
- Global Research Antibodies Market – Size, Outlook, Trends and Forecast (2023 – 2030)
Antibodies are disease-fighting protein developed by the body in response to the presence of the antigen. Global Research Antibodies market value is projected to be $9.33 Billion in 2017 and is expected to generate revenue of around $14.21 Billion by the end of 2024, growing at a CAGR of around 6.2% between 2017 and 2024. Rising industry-academia collaborations and innovations in research antibodies technologies are the factors enhancing the growth of the market. Stringent government regulations and cost- and time-intensive antibody development processes are the factors which hamper the market growth. Increasing demand for personalised medicine and protein therapeutics and growth in stem cell and neurobiology research are the opportunities for Research Antibodies market.
Research Study Objectives:
- Define, estimate, and forecast the Research Antibodies market statistics by product, application, technology, end user and regions concerning the individual growth drivers, market trends and their contribution toward the Research Antibodies market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Research Antibodies Market Analysis
- Analysis and conclusions on the future Research Antibodies market outlook.
Top-down and bottom-up approaches are used to validate the Research Antibodies Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Research Antibodies Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Research Antibodies market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Research Antibodies market segmentation is as follows:
By Technology
- Western blotting
- Enzyme-linked immunosorbent assay (ELISA)
- Flow cytometry
- Immunoprecipitation
- Immunofluorescence
- Immunohistochemistry
- Other technologies
By Product
- Reagents
- Antibodies
By Application
- Proteomics
- Drug development
- Genomics
By End User
- Pharmaceutical & biotechnology companies
- Academic & research institutes
- Contract research organisations
Geographical Analysis:
Research Antibodies market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Research Antibodies Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Research Antibodies Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Research Antibodies market players, such as
- Bio – Rad Laboratories.
- Merck Millipore
- Danaher Corporation.
- Becton, Dickinson and Company.
- International Medical Group.
- Along with these companies, many other companies are considered in the report while analysing the Global Research Antibodies competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing number of industry-academia collaborations
4.1.2. Growing research activity, funding for R&D
4.1.3. Innovations in research antibodies technologies
4.1.4. Rising stem cells and neurobiology research
4.2. Market Restraints & Challenges
4.2.1.Stringent government regulations
4.2.2. Cost- and time-intensive antibody development processes
4.3. Market Opportunities
4.3.1. Growing demand for personalised medicine and protein therapeutics
4.3.2. Growth in stem cell and neurobiology research
CHAPTER 5. GLOBAL RESEARCH ANTIBODIES MARKET – BY TECHNOLOGY
5.1. Introduction
5.2. Western blotting
5.3. Enzyme-linked immunosorbent assay (ELISA)
5.4. Flow cytometry
5.5. Immunoprecipitation
5.6. Immunofluorescence
5.7. Immunohistochemistry
5.8. Other technologies
CHAPTER 6. GLOBAL RESEARCH ANTIBODIES MARKET – BY PRODUCT
6.1.Introduction
6.2. Reagents
6.2.1. Media & sera
6.2.2. Stains & Dyes
6.2.3. Fixatives
6.2.4. Buffers
6.2.5. Solvents
6.2.6. Enzymes
6.2.7. Probes
6.2.8. Other reagents
6.3. Antibodies
6.3.1. Antibodies, by type
6.3.1.1. Primary antibodies
6.3.1.2. Secondary antibodies
6.3.2. Antibodies, by source
6.3.2.1. Mice
6.3.2.2. Rabbits
6.3.2.3. Other sources
6.3.3. Antibodies, by research area
6.3.3.1. Oncology
6.3.3.2. Infectious diseases
6.3.3.3. Immunology
6.3.3.4. Neurobiology
6.3.3.5. Stem cells
6.3.3.6. Other research areas
CHAPTER 7. GLOBAL RESEARCH ANTIBODIES MARKET – BY APPLICATION
7.1. Introduction services
7.2. Proteomics
7.3. Drug development
7.4. Genomics
CHAPTER 8. GLOBAL RESEARCH ANTIBODIES MARKET – BY END USER
8.1. Introduction
8.2. Pharmaceutical & biotechnology companies
8.3. Academic & research institutes
8.4. Contract research organisations
CHAPTER 9. GLOBAL RESEARCH ANTIBODIES MARKET – BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL RESEARCH ANTIBODIES MARKET – COMPANY
PROFILES
10.1.Biolegend, Inc.
10.2. Perkinelmer, Inc.
10.3.GenScriptCorporation.
10.4. Abcam PLC.
10.5. Bio-Rad Laboratories
10.6. Merck Millipore.
10.7. Lonza Group
10.8. Thermo Fisher Scientific.
10.9. Cell Signalling Technology, Inc.
10.10. F.Hoffmann La Roche Ltd.,
10.11. Danaher Corporation.
10.12. Becton, Dickinson and Company
10.13. International Medical Group.
10.14. Merck Group
10.15. Allianz SE.
CHAPTER 11. GLOBAL RESEARCH ANTIBODIES MARKET – COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3.Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,561.91 - €7,685.74
- INR: ₹224,524.77 - ₹673,574.30
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,211.78 - £6,635.33
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Antibodies are disease-fighting protein developed by the body in response to the presence of the antigen. Global Research Antibodies market value is projected to be $9.33 Billion in 2017 and is expected to generate revenue of around $14.21 Billion by the end of 2024, growing at a CAGR of around 6.2% between 2017 and 2024. Rising industry-academia collaborations and innovations in research antibodies technologies are the factors enhancing the growth of the market. Stringent government regulations and cost- and time-intensive antibody development processes are the factors which hamper the market growth. Increasing demand for personalised medicine and protein therapeutics and growth in stem cell and neurobiology research are the opportunities for Research Antibodies market.
Research Study Objectives:
- Define, estimate, and forecast the Research Antibodies market statistics by product, application, technology, end user and regions concerning the individual growth drivers, market trends and their contribution toward the Research Antibodies market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Research Antibodies Market Analysis
- Analysis and conclusions on the future Research Antibodies market outlook.
Top-down and bottom-up approaches are used to validate the Research Antibodies Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Research Antibodies Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Research Antibodies market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Research Antibodies market segmentation is as follows:
By Technology
- Western blotting
- Enzyme-linked immunosorbent assay (ELISA)
- Flow cytometry
- Immunoprecipitation
- Immunofluorescence
- Immunohistochemistry
- Other technologies
By Product
- Reagents
- Antibodies
By Application
- Proteomics
- Drug development
- Genomics
By End User
- Pharmaceutical & biotechnology companies
- Academic & research institutes
- Contract research organisations
Geographical Analysis:
Research Antibodies market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Research Antibodies Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Research Antibodies Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Research Antibodies market players, such as
- Bio – Rad Laboratories.
- Merck Millipore
- Danaher Corporation.
- Becton, Dickinson and Company.
- International Medical Group.
- Along with these companies, many other companies are considered in the report while analysing the Global Research Antibodies competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing number of industry-academia collaborations
4.1.2. Growing research activity, funding for R&D
4.1.3. Innovations in research antibodies technologies
4.1.4. Rising stem cells and neurobiology research
4.2. Market Restraints & Challenges
4.2.1.Stringent government regulations
4.2.2. Cost- and time-intensive antibody development processes
4.3. Market Opportunities
4.3.1. Growing demand for personalised medicine and protein therapeutics
4.3.2. Growth in stem cell and neurobiology research
CHAPTER 5. GLOBAL RESEARCH ANTIBODIES MARKET – BY TECHNOLOGY
5.1. Introduction
5.2. Western blotting
5.3. Enzyme-linked immunosorbent assay (ELISA)
5.4. Flow cytometry
5.5. Immunoprecipitation
5.6. Immunofluorescence
5.7. Immunohistochemistry
5.8. Other technologies
CHAPTER 6. GLOBAL RESEARCH ANTIBODIES MARKET – BY PRODUCT
6.1.Introduction
6.2. Reagents
6.2.1. Media & sera
6.2.2. Stains & Dyes
6.2.3. Fixatives
6.2.4. Buffers
6.2.5. Solvents
6.2.6. Enzymes
6.2.7. Probes
6.2.8. Other reagents
6.3. Antibodies
6.3.1. Antibodies, by type
6.3.1.1. Primary antibodies
6.3.1.2. Secondary antibodies
6.3.2. Antibodies, by source
6.3.2.1. Mice
6.3.2.2. Rabbits
6.3.2.3. Other sources
6.3.3. Antibodies, by research area
6.3.3.1. Oncology
6.3.3.2. Infectious diseases
6.3.3.3. Immunology
6.3.3.4. Neurobiology
6.3.3.5. Stem cells
6.3.3.6. Other research areas
CHAPTER 7. GLOBAL RESEARCH ANTIBODIES MARKET – BY APPLICATION
7.1. Introduction services
7.2. Proteomics
7.3. Drug development
7.4. Genomics
CHAPTER 8. GLOBAL RESEARCH ANTIBODIES MARKET – BY END USER
8.1. Introduction
8.2. Pharmaceutical & biotechnology companies
8.3. Academic & research institutes
8.4. Contract research organisations
CHAPTER 9. GLOBAL RESEARCH ANTIBODIES MARKET – BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL RESEARCH ANTIBODIES MARKET – COMPANY
PROFILES
10.1.Biolegend, Inc.
10.2. Perkinelmer, Inc.
10.3.GenScriptCorporation.
10.4. Abcam PLC.
10.5. Bio-Rad Laboratories
10.6. Merck Millipore.
10.7. Lonza Group
10.8. Thermo Fisher Scientific.
10.9. Cell Signalling Technology, Inc.
10.10. F.Hoffmann La Roche Ltd.,
10.11. Danaher Corporation.
10.12. Becton, Dickinson and Company
10.13. International Medical Group.
10.14. Merck Group
10.15. Allianz SE.
CHAPTER 11. GLOBAL RESEARCH ANTIBODIES MARKET – COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3.Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.